| Literature DB >> 15877284 |
Hekun Liu1, Sizhong Zhang, Jianyin Lin, Hai Li, Aimin Huang, Cuiying Xiao, Xuefei Li, Zhiguang Su, Chunting Wang, Daniel W Nebert, Bing Zhou, Keqin Zheng, Jiajun Shi, Guixin Li, Dejia Huang.
Abstract
The recently discovered apolipoprotein A5 ( APOA5 ) gene has been shown to be important in determining plasma triglyceride levels, a major cardiovascular disease risk factor. We searched for possible associations of the APOA5 gene polymorphisms S19W and -1131T>C with coronary heart disease (CHD) in a Chinese population. A total of 483 Chinese CHD patients and 502 control non-CHD subjects were genotyped by polymerase chain reaction-restriction fragment length polymorphism for these 2 single nucleotide polymorphisms. We found that the minor allele 19W was observed only in CHD patients and not in controls, with allelic frequencies of 0.047 and 0.000, respectively ( P < .000001), and the minor allele -1131C was significantly higher in CHD patients than in controls (0.391 vs 0.299, P < .0001). These results suggest that both the S19W and -1131T>C variations in the APOA5 gene are associated with the CHD and appear to be 2 genetic risk factors for CHD susceptibility in Chinese. Moreover, we found that triglyceride levels were significantly higher in -1131C carriers than in -1131T subjects of the control group and that high-density-lipoprotein cholesterol was decreased in -1131C carriers among CHD patients.Entities:
Mesh:
Substances:
Year: 2005 PMID: 15877284 DOI: 10.1016/j.metabol.2004.11.009
Source DB: PubMed Journal: Metabolism ISSN: 0026-0495 Impact factor: 8.694